European Heart Journal Advance Access first published online on January 28, 2005
This version published online on February 2, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi044
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 Division of Cardiology, Helsinki University Central Hospital, Haartmaninkatu 4, 00290 Helsinki, Finland
* To whom correspondence should be addressed.
ESC Guidelines
Executive summary of the guidelines on the diagnosis and treatment of acute heart failure: The Task Force on Acute Heart Failure of the European Society of Cardiology
2 (Germany)
3 (UK)
4 (Greece)
5 (France)
6 (Israel)
7 (Spain)
8 (Italy)
9 (Sweden)
10 (Poland)
11 (The Netherlands)
12 (Portugal)
13 (Turkey)
14 (Norway)
15 (Switzerland)
16 (Denmark)
Markku S. Nieminen Chairperson, E-mail: markku.nieminen{at}hus.fi
The originally published version of this paper was incorrect. Table 11 contained incorrect dosages for milrinone, enoximone, and levosimendan. The corresponding text for levosimendan on page 19, section 10.7.6. was also incorrect. Corections have also been made to pages 9, 17, 19, and 24.
CiteULike 
Connotea 
Del.icio.us What's this?
This article has been cited by other articles:
|
|
 |
|
  M. Gheorghiade, J. E.A. Blair, G. S. Filippatos, C. Macarie, W. Ruzyllo, J. Korewicki, S. I. Bubenek-Turconi, M. Ceracchi, M. Bianchetti, P. Carminati, et al. Hemodynamic, Echocardiographic, and Neurohormonal Effects of Istaroxime, a Novel Intravenous Inotropic and Lusitropic Agent: A Randomized Controlled Trial in Patients Hospitalized With Heart Failure J. Am. Coll. Cardiol., June 10, 2008; 51(23): 2276 - 2285. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 L. A. Allen, J. E. Yager, M. J. Funk, W. C. Levy, J. A. Tulsky, M. T. Bowers, G. C. Dodson, C. M. O'Connor, and G. M. Felker Discordance Between Patient-Predicted and Model-Predicted Life Expectancy Among Ambulatory Patients With Heart Failure JAMA, June 4, 2008; 299(21): 2533 - 2542. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. Borrows, M. Loucaidou, G. Chusney, S. Borrows, J. V. Tromp, T. Cairns, M. Griffith, N. Hakim, A. McLean, A. Palmer, et al. Anaemia and congestive heart failure early post-renal transplantation Nephrol. Dial. Transplant., May 1, 2008; 23(5): 1728 - 1734. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 H. J. Verberne, L. M. Brewster, G. A. Somsen, and B. L.F. van Eck-Smit Prognostic value of myocardial 123I-metaiodobenzylguanidine (MIBG) parameters in patients with heart failure: a systematic review Eur. Heart J., May 1, 2008; 29(9): 1147 - 1159. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J T Parissis, M Nikolaou, D Farmakis, V Bistola, I A Paraskevaidis, S Adamopoulos, G Filippatos, and D T Kremastinos Clinical and prognostic implications of self-rating depression scales and plasma B-type natriuretic peptide in hospitalised patients with chronic heart failure Heart, May 1, 2008; 94(5): 585 - 589. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. Hammerer-Lercher, B. Halfinger, B. Sarg, J. Mair, B. Puschendorf, A. Griesmacher, N. A. Guzman, and H. H. Lindner Analysis of Circulating Forms of proBNP and NT-proBNP in Patients with Severe Heart Failure Clin. Chem., May 1, 2008; 54(5): 858 - 865. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W F Peacock, J E Hollander, D B Diercks, M Lopatin, G Fonarow, and C L Emerman Morphine and outcomes in acute decompensated heart failure: an ADHERE analysis Emerg. Med. J., April 1, 2008; 25(4): 205 - 209. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. S. Pang, J. G.F. Cleland, J. R. Teerlink, S. P. Collins, C. J. Lindsell, G. Sopko, W. F. Peacock, G. C. Fonarow, A. Z. Aldeen, J. D. Kirk, et al. A proposal to standardize dyspnoea measurement in clinical trials of acute heart failure syndromes: the need for a uniform approach Eur. Heart J., March 2, 2008; 29(6): 816 - 824. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
F. Zannad, W. G. Stough, B. Pitt, J. G.F. Cleland, K. F. Adams, N. L. Geller, C. Torp-Pedersen, B.-A. Kirwan, and F. Follath Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition Eur. Heart J., February 1, 2008; 29(3): 413 - 421. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 J Amit Benjamin and K E Lewis Sleep-disordered breathing and cardiovascular disease Postgrad. Med. J., January 1, 2008; 84(987): 15 - 22. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 A. A. Pitsis, A. N. Visouli, D. Burkhoff, P. Dardas, N. Mezilis, G. Bougioukas, and G. Filippatos Feasibility Study of a Temporary Percutaneous Left Ventricular Assist Device in Cardiac Surgery Ann. Thorac. Surg., December 1, 2007; 84(6): 1993 - 1999. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
P. Plaisance, R. Pirracchio, C. Berton, E. Vicaut, and D. Payen A randomized study of out-of-hospital continuous positive airway pressure for acute cardiogenic pulmonary oedema: physiological and clinical effects Eur. Heart J., December 1, 2007; 28(23): 2895 - 2901. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Masip Early continuous positive airway pressure in acute cardiogenic pulmonary oedema Eur. Heart J., December 1, 2007; 28(23): 2823 - 2824. [Full Text] [PDF]
|
|
|
|
|
|
J. J. V. McMurray, J. R. Teerlink, G. Cotter, R. C. Bourge, J. G. F. Cleland, G. Jondeau, H. Krum, M. Metra, C. M. O'Connor, J. D. Parker, et al. Effects of Tezosentan on Symptoms and Clinical Outcomes in Patients With Acute Heart Failure: The VERITAS Randomized Controlled Trials JAMA, November 7, 2007; 298(17): 2009 - 2019. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 O. Penuelas MD, F. Frutos-Vivar MD, and A. Esteban MD PhD Noninvasive positive-pressure ventilation in acute respiratory failure Can. Med. Assoc. J., November 6, 2007; 177(10): 1211 - 1218. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
T. Breidthardt, M. Christ, M. Matti, D. Schrafl, K. Laule, M. Noveanu, T. Boldanova, T. Klima, W. Hochholzer, A. P Perruchoud, et al. QRS and QTc interval prolongation in the prediction of long-term mortality of patients with acute destabilised heart failure Heart, September 1, 2007; 93(9): 1093 - 1097. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Lassus, V.-P. Harjola, R. Sund, K. Siirila-Waris, J. Melin, K. Peuhkurinen, K. Pulkki, M. S. Nieminen, and for the FINN-AKVA Study group Prognostic value of cystatin C in acute heart failure in relation to other markers of renal function and NT-proBNP Eur. Heart J., August 1, 2007; 28(15): 1841 - 1847. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Emdin, C. Passino, C. Prontera, M. Fontana, R. Poletti, A. Gabutti, C. Mammini, A. Giannoni, L. Zyw, G. Zucchelli, et al. Comparison of Brain Natriuretic Peptide (BNP) and Amino-Terminal ProBNP for Early Diagnosis of Heart Failure Clin. Chem., July 1, 2007; 53(7): 1289 - 1297. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
G. Piccirillo, D. Magri, S. Matera, M. Magnanti, A. Torrini, E. Pasquazzi, E. Schifano, S. Velitti, V. Marigliano, R. Quaglione, et al. QT variability strongly predicts sudden cardiac death in asymptomatic subjects with mild or moderate left ventricular systolic dysfunction: a prospective study Eur. Heart J., June 1, 2007; 28(11): 1344 - 1350. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Nunez, E. Nunez, L. Consuegra, J. Sanchis, V. Bodi, A. Martinez-Brotons, V. Bertomeu-Gonzalez, R. Robles, M. J Bosch, L. Facila, et al. Carbohydrate antigen 125: an emerging prognostic risk factor in acute heart failure? Heart, June 1, 2007; 93(6): 716 - 721. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
E. B Friedrich and M. Bohm MANAGEMENT OF END STAGE HEART FAILURE Heart, May 1, 2007; 93(5): 626 - 631. [Full Text] [PDF]
|
|
|
|
|
|
A. Clerico, M. Fontana, L. Zyw, C. Passino, and M. Emdin Comparison of the Diagnostic Accuracy of Brain Natriuretic Peptide (BNP) and the N-Terminal Part of the Propeptide of BNP Immunoassays in Chronic and Acute Heart Failure: A Systematic Review Clin. Chem., May 1, 2007; 53(5): 813 - 822. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 P. S. Pagel Levosimendan in Cardiac Surgery: A Unique Drug for the Treatment of Perioperative Left Ventricular Dysfunction or Just Another Inodilator Searching for a Clinical Application? Anesth. Analg., April 1, 2007; 104(4): 759 - 761. [Full Text] [PDF]
|
|
|
|
|
|
M. Gheorghiade, M. A. Konstam, J. C. Burnett Jr, L. Grinfeld, A. P. Maggioni, K. Swedberg, J. E. Udelson, F. Zannad, T. Cook, J. Ouyang, et al. Short-term Clinical Effects of Tolvaptan, an Oral Vasopressin Antagonist, in Patients Hospitalized for Heart Failure: The EVEREST Clinical Status Trials JAMA, March 28, 2007; 297(12): 1332 - 1343. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. A. Allen and C. M. O'Connor Management of acute decompensated heart failure Can. Med. Assoc. J., March 13, 2007; 176(6): 797 - 805. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 R. J A Frost, C. Sonne, U. Wehr, and H.-U. Stempfle Effects of calcium supplementation on bone loss and fractures in congestive heart failure Eur. J. Endocrinol., March 1, 2007; 156(3): 309 - 314. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 W S A Smellie, J Forth, J J Coleman, W Irvine, P C Dore, G Handley, D G Williams, P J Galloway, K G Kerr, R Herriot, et al. Best practice in primary care pathology: review 6 J. Clin. Pathol., March 1, 2007; 60(3): 225 - 234. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Camm, H. Klein, and S. Nisam The cost of implantable defibrillators: perceptions and reality Eur. Heart J., February 2, 2007; 28(4): 392 - 397. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, A. Vahanian, H. Baumgartner, J. Bax, E. Butchart, R. Dion, G. Filippatos, F. Flachskampf, R. Hall, B. Iung, et al. Guidelines on the management of valvular heart disease: The Task Force on the Management of Valvular Heart Disease of the European Society of Cardiology Eur. Heart J., January 26, 2007; (2007) ehl428v1. [Full Text] [PDF]
|
|
|
|
|
|
K. Siirila-Waris, J. Lassus, J. Melin, K. Peuhkurinen, M. S. Nieminen, V.-P. Harjola, and for the FINN-AKVA study group Characteristics, outcomes, and predictors of 1-year mortality in patients hospitalized for acute heart failure Eur. Heart J., December 2, 2006; 27(24): 3011 - 3017. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
C-H Huang, M-S Tsai, C-C Hsieh, T-D Wang, W-T Chang, and W-J Chen Diagnostic accuracy of tissue Doppler echocardiography for patients with acute heart failure Heart, December 1, 2006; 92(12): 1790 - 1794. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
J. Coste, P. Jourdain, and J. Pouchot A Gray Zone Assigned to Inconclusive Results of Quantitative Diagnostic Tests: Application to the Use of Brain Natriuretic Peptide for Diagnosis of Heart Failure in Acute Dyspneic Patients Clin. Chem., December 1, 2006; 52(12): 2229 - 2235. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. S. Nieminen, D. Brutsaert, K. Dickstein, H. Drexler, F. Follath, V.-P. Harjola, M. Hochadel, M. Komajda, J. Lassus, J. L. Lopez-Sendon, et al. EuroHeart Failure Survey II (EHFS II): a survey on hospitalized acute heart failure patients: description of population Eur. Heart J., November 2, 2006; 27(22): 2725 - 2736. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Developed in Collaboration With the European Heart, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death: A Report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) J. Am. Coll. Cardiol., September 5, 2006; 48(5): e247 - e346. [Full Text] [PDF]
|
|
|
|
 |
|
 R. R. Arora Nesiritide: trials and tribulations. Journal of Cardiovascular Pharmacology and Therapeutics, September 1, 2006; 11(3): 165 - 169. [Abstract] [PDF]
|
|
|
|
 |
|
 M. B. Vroom An overview of inotropic agents. Seminars in Cardiothoracic and Vascular Anesthesia, September 1, 2006; 10(3): 246 - 252. [Abstract] [PDF]
|
|
|
|
 |
|
 Writing Committee Members, D. P. Zipes, A. J. Camm, M. Borggrefe, A. E. Buxton, B. Chaitman, M. Fromer, G. Gregoratos, G. Klein, A. J. Moss, et al. ACC/AHA/ESC 2006 guidelines for management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: A report of the American College of Cardiology/American Heart Association Task Force and the European Society of Cardiology Committee for Practice Guidelines (Writing Committee to Develop Guidelines for Management of Patients With Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death) Developed in collaboration with the European Heart Rhythm Association and the Heart Rhythm Society Europace, September 1, 2006; 8(9): 746 - 837. [Full Text] [PDF]
|
|
|
|
 |
|
 M. S. Nieminen Key issues of European Society of Cardiology guidelines on acute heart failure Eur. Heart J. Suppl., September 1, 2006; 8(suppl_E): E6 - E11. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Groban and J. Butterworth Perioperative management of chronic heart failure. Anesth. Analg., September 1, 2006; 103(3): 557 - 575. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. De Luca, W. S. Colucci, M. S. Nieminen, B. M. Massie, and M. Gheorghiade Evidence-based use of levosimendan in different clinical settings Eur. Heart J., August 2, 2006; 27(16): 1908 - 1920. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
K.-H. Kuck and S. Nisam ICD therapy: 'the sickest benefit the most...': what about the less sick? Europace, July 1, 2006; 8(7): 508 - 511. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L. Tavazzi, A. P. Maggioni, D. Lucci, G. Cacciatore, G. Ansalone, F. Oliva, M. Porcu, and on behalf of the Italian survey on Acute Heart Fai Nationwide survey on acute heart failure in cardiology ward services in Italy Eur. Heart J., May 2, 2006; 27(10): 1207 - 1215. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. R. Cowie, M. Komajda, T. Murray-Thomas, J. Underwood, B. Ticho, and on behalf of the POSH Investigators Prevalence and impact of worsening renal function in patients hospitalized with decompensated heart failure: results of the prospective outcomes study in heart failure (POSH) Eur. Heart J., May 2, 2006; 27(10): 1216 - 1222. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
L Purek, K Laule-Kilian, A Christ, T Klima, M E Pfisterer, A P Perruchoud, and C Mueller Coronary artery disease and outcome in acute congestive heart failure Heart, May 1, 2006; 92(5): 598 - 602. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
O. Kamp Advanced Systolic and Diastolic Function: Beyond the E-and A-wave Seminars in Cardiothoracic and Vascular Anesthesia, March 1, 2006; 10(1): 63 - 65. [Abstract] [PDF]
|
|
|
|
 |
|
 N. D Gillespie The diagnosis and management of chronic heart failure in the older patient Br. Med. Bull., February 22, 2006; 75-76(1): 49 - 62. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
M. Rauchhaus, W. Doehner, and S. D. Anker Heart failure therapy: testosterone replacement and its implications Eur. Heart J., January 1, 2006; 27(1): 10 - 12. [Full Text] [PDF]
|
|
|
|
|
|
J. Masip, M. Roque, B. Sanchez, R. Fernandez, M. Subirana, and J. A. Exposito Noninvasive Ventilation in Acute Cardiogenic Pulmonary Edema: Systematic Review and Meta-analysis JAMA, December 28, 2005; 294(24): 3124 - 3130. [Abstract] [Full Text] [PDF]
|
|
|
|
 |
|
 M. Gheorghiade, F. Zannad, G. Sopko, L. Klein, I. L. Pina, M. A. Konstam, B. M. Massie, E. Roland, S. Targum, S. P. Collins, et al. Acute Heart Failure Syndromes: Current State and Framework for Future Research Circulation, December 20, 2005; 112(25): 3958 - 3968. [Full Text] [PDF]
|
|
|
|
|
|
W.H. W. Tang and G. S. Francis The Year in Heart Failure J. Am. Coll. Cardiol., December 6, 2005; 46(11): 2125 - 2133. [Full Text] [PDF]
|
|
|
|
 |
|
 G. L Earl and J. T Fitzpatrick Levosimendan: A Novel Inotropic Agent for Treatment of Acute, Decompensated Heart Failure Ann. Pharmacother., November 1, 2005; 39(11): 1888 - 1896. [Abstract] [Full Text] [PDF]
|
|
|
|
|
|
Authors/Task Force Members, K. Swedberg, Writing Committee:, J. Cleland, H. Dargie, H. Drexler, F. Follath, M. Komajda, L. Tavazzi, O. A. Smiseth, et al. Guidelines for the diagnosis and treatment of chronic heart failure: executive summary (update 2005): The Task Force for the Diagnosis and Treatment of Chronic Heart Failure of the European Society of Cardiology Eur. Heart J., June 1, 2005; 26(11): 1115 - 1140. [Full Text] [PDF]
|
|